Clinical practice guidelines for the diagnosis and treatment of scabies

Basit Öğe Kaydı
dc.authoridDEMIR, Gulay/0000-0002-3916-7639
dc.authoridDurdu, Murat/0000-0003-1247-3932
dc.authoridTaylan Ozkan, Aysegul/0000-0001-8421-3625
dc.authoridAktas, Habibullah/0000-0001-9239-1659
dc.contributor.authorUzun, Soner
dc.contributor.authorDurdu, Murat
dc.contributor.authorYurekli, Aslan
dc.contributor.authorMulayim, Mehmet K.
dc.contributor.authorAkyol, Melih
dc.contributor.authorVelipasaoglu, Sevtap
dc.contributor.authorHarman, Mehmet
dc.date.accessioned2025-02-22T14:08:52Z
dc.date.available2025-02-22T14:08:52Z
dc.date.issued2024
dc.departmentDicle Üniversitesien_US
dc.description.abstractScabies, caused by the Sarcoptes scabiei var hominis mite burrowing into the skin, is a highly contagious disease characterized by intense nocturnal itching. Its global impact is considerable, affecting more than 200 million individuals annually and posing significant challenges to healthcare systems worldwide. Transmission occurs primarily through direct skin-to-skin contact, contributing to its widespread prevalence and emergence as a substantial public health concern affecting large populations. This review presents consensus-based clinical practice guidelines for diagnosing and managing scabies, developed through the fuzzy Delphi method by dermatology, parasitology, pediatrics, pharmacology, and public health experts. The presence of burrows containing adult female mites, their eggs, and excreta is the diagnostic hallmark of scabies. Definitive diagnosis typically involves direct microscopic examination of skin scrapings obtained from these burrows, although dermoscopy has become a diagnostic tool in clinical practice. Treatment modalities encompass topical agents, such as permethrin, balsam of Peru, precipitated sulfur, and benzyl benzoate. In cases where topical therapy proves inadequate or in instances of crusted scabies, oral ivermectin is recommended as a systemic treatment option. This comprehensive approach addresses the diagnostic and therapeutic challenges associated with scabies, optimizing patient care, and management outcomes.en_US
dc.identifier.doi10.1111/ijd.17327
dc.identifier.endpage1656en_US
dc.identifier.issn0011-9059
dc.identifier.issn1365-4632
dc.identifier.issue12en_US
dc.identifier.pmid38922701en_US
dc.identifier.scopus2-s2.0-85196636612en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage1642en_US
dc.identifier.urihttps://doi.org/10.1111/ijd.17327
dc.identifier.urihttps://hdl.handle.net/11468/29689
dc.identifier.volume63en_US
dc.identifier.wosWOS:001252213100001en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofInternational Journal of Dermatologyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmzKA_WOS_20250222
dc.subjectscabiesen_US
dc.subjectneglected tropical diseasesen_US
dc.subjectdiagnosticsen_US
dc.subjecttreatmenten_US
dc.subjectinfestationsen_US
dc.subjecteliminationen_US
dc.subjectpreventionen_US
dc.titleClinical practice guidelines for the diagnosis and treatment of scabiesen_US
dc.typeReviewen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu